AtaiBeckley (ATAI) Change in Accured Expenses (2020 - 2026)

AtaiBeckley (ATAI) recorded quarterly Change in Accured Expenses of -$4.1 million in Q1 2026, down 194.27% quarter-over-quarter from -$1.4 million in Q1 2025, and down 194.27% on a YoY basis from $4.4 million in Q1 2025.

AtaiBeckley (ATAI) Change in Accured Expenses (2020 - 2026) Analysis & Trends

AtaiBeckley has disclosed Change in Accured Expenses across 6 years of filings, most recently posting -$3.6 million for Q3 2025.

  • Change in Accured Expenses for Q3 2025 came in at -$3.6 million, down 167.62% year-over-year; the trailing twelve-month figure through Sep 2025 was -$2.1 million (up 4.54% YoY), and the FY2024 annual result was -$6.2 million, down 87.18% from the prior year.
  • Change in Accured Expenses was -$4.1 million for Q1 2026 at AtaiBeckley, down from -$1.4 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of -$1.4 million in Q1 2025 to a low of -$4.1 million in Q1 2026.
  • The 5-year median for Change in Accured Expenses is -$270000.0 (2023), against an average of -$119052.6.
  • Across the five-year window, Change in Accured Expenses soared 6546.73% in 2021 and slumped 404.44% in 2024, its largest moves.
  • AtaiBeckley's Change in Accured Expenses stood at $2.5 million in 2021, then slumped by 248.71% to -$3.7 million in 2022, then jumped by 144.5% to $1.6 million in 2023, then slumped by 246.24% to -$2.4 million in 2024, then tumbled by 51.24% to -$3.6 million in 2025.
  • The last three Change in Accured Expenses figures came in at -$3.6 million (Q3 2025), $5.7 million (Q2 2025), and -$1.7 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 AtaiBeckley 1.45 Bn 1.45 Bn - -4.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.11 Mn
Mar 31, 2026 -4.11 Mn
Sep 30, 2025 -3.65 Mn
Sep 30, 2025 -3.65 Mn
Jun 30, 2025 5.68 Mn
Jun 30, 2025 5.68 Mn
Mar 31, 2025 -1.40 Mn
Mar 31, 2025 -1.40 Mn
Mar 31, 2025 -1.71 Mn
Mar 31, 2025 -1.71 Mn
Dec 31, 2024 -2.41 Mn
Dec 31, 2024 -2.41 Mn
Sep 30, 2024 -1.36 Mn
Sep 30, 2024 -1.36 Mn
Jun 30, 2024 1.82 Mn
Jun 30, 2024 1.82 Mn
Mar 31, 2024 -4.29 Mn
Mar 31, 2024 -4.29 Mn
Dec 31, 2023 1.65 Mn
Dec 31, 2023 1.65 Mn